Inventor · disambiguated record
Lori Westendorf
Also filed as: WESTENDORF LORI
11 granted patents·14 pending applications·11 citations·filing 2016–2025
84Inventor score
Top patents by PatentIndex Score
25 records- 0195US11078291B2BCMA antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2019·Granted Aug 3, 2021·8 cites·66 claims
- 0289US11767365B2BCMA antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2021·Granted Sep 26, 2023·1 cites·73 claims
- 0384US2024109975A1Bcma antibodies and use of same to treat cancer and immunological disordersSEAGEN INC·Filed 2023·Application pending·0 cites
- 0477US11819553B2Glypican 3 antibodies and conjugates thereofSEAGEN INC·Filed 2019·Granted Nov 21, 2023·1 cites·21 claims
- 0576US10912842B2CD123 antibodies and conjugates thereofSEATTLE GENETICS INC·Filed 2016·Granted Feb 9, 2021·1 cites·53 claims
- 0675US12268751B2Anti-αVβ6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2023·Granted Apr 8, 2025·0 cites·15 claims
- 0773US2024409658A1Anti-cd228 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2024·Application pending·0 cites
- 0871US2024173427A1Glypican 3 antibodies and conjugates thereofSEAGEN INC·Filed 2023·Application pending·0 cites
- 0970US2023218776A1Anti-ntb-a antibodies and related compositions and methodsSEAGEN INC·Filed 2022·Application pending·0 cites
- 1069US2024033369A1Anti-cd228 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 1168US2019023801A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 1266US2019194338A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 1363US12071480B2CD47 antibodies and uses thereof for treating cancerSEAGEN INC·Filed 2021·Granted Aug 27, 2024·0 cites·33 claims
- 1463US2017233484A1Bcma antibodies and use of same to treat cancer and immunological disordersSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 1562US11827709B2Anti-AVB6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2020·Granted Nov 28, 2023·0 cites·104 claims
- 1662US2025242041A1Anti-avb6 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2025·Application pending·0 cites
- 1760US11617798B2Anti-CD228 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2020·Granted Apr 4, 2023·0 cites·114 claims
- 1860US2021128742A1CD123 Antibodies and Conjugates ThereofSEAGEN INC·Filed 2021·Application pending·0 cites
- 1957US2025276076A1Anti-alpp/alppl2 antibodies and antibody-drug conjugatesSEAGEN INC·Filed 2022·Application pending·0 cites
- 2056US11351269B2Anti-NTB-A antibodies and related compositions and methodsSEAGEN INC·Filed 2016·Granted Jun 7, 2022·0 cites·90 claims
- 2154US11180552B2CD47 antibodies and uses thereof for treating cancerSEAGEN INC·Filed 2018·Granted Nov 23, 2021·0 cites·33 claims
- 2253US10722592B2CD48 antibodies and conjugates thereofSEATTLE GENETICS INC·Filed 2016·Granted Jul 28, 2020·0 cites·55 claims
- 2352US2020289661A1Cd48 antibodies and conjugates thereofSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 2451US2022233709A1Masked Antibody FormulationsSEAGEN INC·Filed 2020·Application pending·0 cites
- 2545US2022306727A1Methods of Purifying Masked AntibodiesSEAGEN INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →